- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/31 - Somatostatins
Patent holdings for IPC class A61K 38/31
Total number of patents in this class: 277
10-year publication summary
19
|
32
|
20
|
24
|
25
|
24
|
29
|
16
|
21
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novartis AG | 11234 |
22 |
Amryt Endo, Inc. | 53 |
18 |
Camurus AB | 144 |
17 |
Ipsen Pharma S.A.S. | 387 |
9 |
Salix Pharmaceuticals, Inc. | 91 |
7 |
BCN Peptides, S.A. | 29 |
6 |
Mondobiotech Laboratories AG | 311 |
6 |
Otsuka Pharmaceutical Co., Ltd. | 1545 |
6 |
The Scripps Research Institute | 1353 |
6 |
Rani Therapeutics, LLC | 190 |
5 |
Recordati AG | 53 |
5 |
Mayo Foundation for Medical Education and Research | 3126 |
4 |
Glytech, Inc. | 70 |
4 |
Nbo Pharma LLC | 4 |
4 |
Evonik Corporation | 105 |
3 |
The Trustees of Columbia University in the City of New York | 3529 |
3 |
Antisense Therapeutics Ltd. | 31 |
3 |
Italfarmaco SpA | 140 |
3 |
New York University | 1690 |
3 |
Tyme, Inc. | 46 |
3 |
Other owners | 140 |